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The C-terminus of gp36 of bacteriophage ’KMV (KMV36C) functions as a
particle-associated muramidase, presumably as part of the injection needle of
the ’KMV genome during infection. Crystals of KMV36C were obtained by
hanging-drop vapour diffusion and diffracted to a resolution of 1.6 A˚. The
crystals belong to the cubic space group P432, with unit-cell parameters
a = b = c = 102.52 A˚. KMV36C shows 30% sequence identity to T4 lysozyme
(PDB code 1l56).
1. Introduction
Bacteriophages are viruses with bacterial host cells. After infection,
they multiply in the cytosol and this is followed by release of the
newly formed progeny virions. In their lytic replication cycle,
bacteriophages have to degrade the bacterial cell wall twice, i.e.
during initial infection and upon lysis induction of the host cell. The
major barrier to overcome is the peptidoglycan (PDG), a rigid layer
within the cell wall that is responsible for cell shape and integrity.
Most dsDNA bacteriophages encode specific PDG lytic enzymes
(lysins) to facilitate infection (as part of the mature phage particle)
and to accomplish lysis through a holin–endolysin system (Young et
al., 2000). These PDG lysins are classified according to the bond that
is hydrolyzed (Fig. 1).
The ’KMV-like phages, with ’KMVas the hallmark representative
of the genus, belong to the Podoviridae and infect Pseudomonas
aeruginosa, an important opportunistic Gram-negative pathogen that
is resistant to many commonly used antibiotics (Lavigne et al., 2003;
Ceyssens et al., 2006).
In silico analysis of ’KMV and mass spectrometry of phage
particles revealed that the C-terminus (amino acids 737–898) of gp36
(KMV36C) represents a muramidase which is presumably part of the
injection needle of ’KMV during infection (Lavigne et al., 2003,
2006). KMV36C shows sequence identity to T4 lysozyme (gp e) and is
apparently highly thermoresistant (Lavigne et al., 2004). The re-
markable thermoresistance of KMV36C might be explained by
oligomerization during the unfolding of the protein, which protects
KMV36C from further irreversible denaturation. Furthermore,
KMV36C is able to refold while conserving its (partially) intact
structure (Briers et al., 2006). All this is in agreement with the
carpenter’s rule model, a hypothesis proposed for the functional
analogue gp16 of bacteriophage T7, i.e. gp16 migrates through the
head–tail connection and the tail in an unfolded conformation and
refolds within the cell wall, thereby forming a channel for DNA
injection (Molineux, 2001). The in vivo existence of a functional
unfolded conformation of KMV36C is in agreement with the strong
thermoresistance to irreversible denaturation.
Careful analysis of the crystal structure of KMV36C should allow a
search for the determinants responsible for its exceptional thermo-
resistance. Furthermore, a start could be made in refining a model
system for the infection mechanism of the Podoviridae in general and
the new ’KMV-like genus in particular.
# 2008 International Union of Crystallography
All rights reserved
2. Materials and methods
2.1. Protein expression and purification
KMV36C was recombinantly expressed in Escherichia coli with a
C-terminal E-tag and 6His tag as described previously (Lavigne et
al., 2004). The E-tag is an epitope that is recognized by the
commercially available anti-E-tag antibody (Amersham Biosciences,
Uppsala, Sweden). The cell pellet from a 1.5 l expression culture was
resuspended in 60 ml lysis buffer (20 mM NaH2PO4, 0.5M NaCl,
10 mM imidazole pH 7.4). After three freeze–thaw cycles, the lysate
was clarified by sonication, centrifugation (3313g, 30 min, 277 K) and
filtration (0.45 and 0.22 mm pore size). The protein was purified using
a two-step chromatography protocol. The filtrate was applied onto a
1 ml Ni–NTA HisTrap column (GE Healthcare, Buckinghamshire,
England). Metal-affinity purification was performed according to the
manufacturer’s instructions using 50 mM imidazole in the equilibra-
tion and wash buffer. The protocol was run as three loops of 20 ml
filtrate in order to prevent column saturation. The volume of the
pooled fractions was reduced to 8 ml using a centrifugal filter device
(Centriplus YM-30, Amicon, Millipore, Massachusetts, USA) and
loaded onto a HiPrep 26/60 Sephacryl S-100 gel-filtration column
(GE Healthcare, Buckinghamshire, England). The elution buffer was
0.05M NaH2PO4, 0.15M NaCl pH 7.2 with a flow rate of 1 ml min
1.
2 ml fractions of purified recombinant protein were pooled up to
38 ml (1.024 mg ml1). The molecular weight of the recombinant
KMV36C was 20 884 Da as determined by SELDI–TOF analysis.
MALDI–TOF mass spectrometry was used to control the purity of
the protein sample prior to the crystallization process. The MALDI–
TOF MS was performed on an ABI-4800 (Applied Biosystems)
proteomic analyzer operating in linear mode. Sinapinic acid
(5 mg ml1) was used as the matrix.
2.2. Crystallization
The protein was concentrated to approximately 20 mg ml1 using a
centrifugal filter device (Centriplus YM-30, Amicon, Millipore,
Massachusetts, USA) and buffered in 0.05M NaH2PO4–NaOH,
0.15 M NaCl pH 7.2. The concentration was estimated spectro-
photometrically and was considered to be an optimal value for the
initial crystallization screens as determined using PCT from Hampton
Research (Watson & O’Callaghan, 2005). Crystallization trials were
performed in Linbro plates (Hampton Research, Aliso Viejo, USA)
using the hanging-drop vapour-diffusion method at 289 K. Crystal
Screens I and II from Hampton Research (Aliso Viejo, USA) and
Structure Screens 1 and 2 from MDL (Molecular Dimensions Ltd,
Suffolk, England) were tested as precipitants. Crystals suitable for
X-ray diffraction analysis appeared after approximately one week in
condition No. 26 and No. 32 of Crystal Screen II [0.1 M sodium
chloride, 0.1M HEPES pH 7.5, 1.6M ammonium sulfate and 0.2M
ammonium sulfate, 0.1M MES pH 6.5, 30%(w/v) PEG mono-
methylether 5000, respectively] as well as in the same conditions from
Structure Screen 2 (No. 14 and No. 26). Therefore, 1.5 ml protein
solution was mixed with 1.5 ml screening solution using a 0.5 ml
reservoir of the same screening solution. The quality of the crystals
obtained using Crystal Screen II (Fig. 2) was tested on a Bruker
Smart 6000 CCD system with cryocooling, showing the necessity of
using synchrotron radiation. Notably, the diffraction pattern of
crystals obtained using condition No. 32 showed ice-ring formation,
which could be removed by using 30%(w/v) PEG 6000 as a cryo-
protectant. Crystals obtained using condition No. 26 showed no ice-
ring formation, but were of poorer diffraction quality.
2.3. Data collection and processing
A single crystal with dimensions of 0.3  0.3  0.2 mm (condition
No. 32) was used to collect a 96.7% complete data set at EMBL
beamline BW7b of the DESY synchrotron in Hamburg. Data were
collected on a MAR345 imaging-plate detector with  = 0.8423 A˚, a
190 ’ range, a 1 increment and a crystal-to-detector distance of
220 mm. The crystal was cryoprotected by quickly washing the crystal
in a 30%(w/v) PEG 6000 solution and was immediately flash-cooled
in a liquid-nitrogen cryostream at 100 K. Overloaded reflection data
were collected using the same crystal with a crystal-to-detector
distance of 310 mm. A total of 24 126 unique reflections were
observed in the resolution range 34.2–1.6 A˚ (Rmerge = 0.107).
Although the resolution edge of the diffraction pattern was 1.43 A˚
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Figure 2
Typical crystals of KMV36C obtained by hanging-drop vapour diffusion using
condition No. 32 from Crystal Screen II. The largest crystal at the top of the picture
is approximately 0.3 mm in length.
Figure 1
Biochemical classification of PDG lysins: 1, amidases; 2, endopeptidases; 3,
glucosaminidases; 4, lysozymes (or muramidases); 5, transglycosylases. The latter
hydrolyze the -1,4-glycosidic bond to form a 1,6-anhydro bond. GlcNAc,
N-acetylglucosamine; MurNAc, N-acetylmuramic acid; m-DAP, meso-diaminopi-
melic acid.
(Fig. 3), careful analysis showed that the data in the outermost shells
were of much lower quality; therefore, the resolution cutoff was
chosen at 1.6 A˚. Data were processed with MOSFLM v.7.0.0 (Leslie,
1992) and scaled using SCALA v.3.2.25 (Evans, 1997). The latter was
used as part of the CCP4 suite (Collaborative Computational Project,
Number 4, 1994). Data-collection statistics for KMV36C are given in
Table 1.
3. Results and discussion
The crystals most likely belong to the primitive cubic space group
P432, with unit-cell parameters a = b = c = 102.52 A˚, which was
confirmed using POINTLESS v.1.2.0 (Collaborative Computational
Project, Number 4, 1994). The Matthews coefficient (VM) is
2.15 A˚3 Da1 for one protein molecule in the asymmetric unit,
resulting in a solvent fraction of 42.9%. When performing a BLASTP
search (Altschul et al., 2005), 30% sequence identity (47% positives)
and an E value of 1  1010 were found for T4 lysozyme with PDB
code 1l56 (Nicholson & Matthews, 1992).
Structure determination by molecular replacement (MR) is
currently in progress using T4 lysozyme structures as MR models.
However, as many attempts to date have failed to solve the structure
by MR and the unit-cell and space-group assignments have already
indicated a possibly significantly different structure, as an alternative
MAD/SAD phasing will be performed using the anomalous signal
from selenomethionine variants, which are presently in preparation.
A total of four methionine residues are present in the 162-amino-acid
sequence of KMV36C.
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Table 1
Data-collection statistics for KMV36C.
Values in parentheses are for the outermost resolution shell.
Resolution range (A˚) 34.20–1.60 (1.69–1.60)
Wavelength (A˚) 0.8423
Space group P432
Unit-cell parameters (A˚, ) a = b = c = 102.52,
 =  =  = 90
No. of reflections (full and summed partials) 1321888 (135314)
No. of unique reflections 24126 (3553)
Mosaicity () 0.25
Completeness (%) 96.7 (100.0)
Rmerge (%) 10.7 (63.0)
Mean I/(I) 40.6 (7.5)
Multiplicity 54.8 (38.1)
Solvent content (%) 42.9
Figure 3
1 oscillation image of a crystal of KMV36C taken on a MARResearch image plate
on beamline BW7b (EMBL, Hamburg). The resolution edge of the image is 1.43 A˚.
